共 360 条
[1]
Burmester GR(2014)Emerging cell and cytokine targets in rheumatoid arthritis Nat Rev Rheumatol 10 77-88
[2]
Feist E(2019)Current therapeutic options in the treatment of rheumatoid arthritis J Clin Med 8 E938-26
[3]
Dörner T(2013)Biologic therapy for autoimmune diseases: an update BMC Med 11 88-1003
[4]
Köhler BM(2016)2015 American College of Rheumatology Guideline for the treatment of rheumatoid arthritis Arthritis Rheum 68 1-56
[5]
Günther J(2010)Economic aspects of treatment options in rheumatoid arthritis: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis Ann Rheum Dis 69 995-1600
[6]
Kaudewitz D(2017)Improvement at any cost? The art and science of choosing treatment strategies for rheumatoid arthritis Ann Intern Med 167 55-2147
[7]
Lorenz HM(2011)Cost-effectiveness of combination nonbiologic disease-modifying antirheumatic drug strategies in patients with early rheumatoid arthritis J Rheumatol 38 1593-1368
[8]
Rosman Z(2016)Best cost-effectiveness and worker productivity with initial triple-DMARD therapy compared with methotrexate monotherapy in early rheumatoid arthritis: cost-utility analysis of the tREACH trial Rheumatology (Oxford) 55 2138-15
[9]
Shoenfeld Y(2019)Rheumatoid Arthritis Treatment. A Back to the Drawing Board Project or High Expectations for Low Unmet Needs? J Clin Med 8 E1237-341
[10]
Zandman-Goddard G(2020)Treatment strategies are more important than drugs in the management of rheumatoid arthritis Clin Rheumatol 39 1363-345